NADPH-oxidase

Isoform-selective Products

NADPH-oxidase Products

  • All (10)
  • NADPH-oxidase Inhibitors (10)
  • New NADPH-oxidase Products
Catalog No. Product Name Information Product Use Citations Product Validations
S7171 Setanaxib (GKT137831) Setanaxib (GKT137831, GKT831) is a potent, dual NADPH oxidase NOX1/NOX4 inhibitor with Ki of 110 nM and 140 nM, respectively. Treatment with GKT137831 suppresses reactive oxygen species (ROS) production. GKT137831 partly inhibits ferroptosis.
Immunity, 2024, 57(1):52-67.e10
Nat Commun, 2024, 15(1):8663
MedComm (2020), 2024, 5(8):e668
S8639 DPI (Diphenyleneiodonium chloride) DPI (Diphenyleneiodonium chloride) is an inhibitor of NADPH oxidase and also a potent, irreversible, and time-, temperature-dependent iNOS/eNOS inhibitor. Diphenyleneiodonium chloride (DPI) also functions as a TRPA1 activator and selectively inhibits intracellular reactive oxygen species (ROS).
Cell Death Discov, 2024, 10(1):122
PLoS Pathog, 2024, 20(9):e1012553
Int Immunopharmacol, 2024, 143(Pt 2):113504
S6656 VAS2870 VAS2870 is a pan-NADPH oxidase (NOX) inhibitor.
Front Oncol, 2024, 14:1438306
J Nanobiotechnology, 2023, 21(1):117
Biomaterials, 2021, 271:120720
S8974 GSK2795039 GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.
Open Med (Wars), 2024, 19(1):20240898
Int J Mol Sci, 2023, 24(18)14369
Int J Mol Sci, 2023, 10.3390/ijms241814369
S0178 GLX351322 GLX351322 is a NADPH oxidase 4 (NOX4) inhibitor. GLX351322 inhibits hydrogen peroxide production from tetracycline inducible NOX4-overexpressing cells with IC50 of 5 μM.
Cell Commun Signal, 2024, 22(1):393
Cell Commun Signal, 2024, 22(1):393.
Biomed Pharmacother, 2023, 165:115052
S5304 2-Acetylphenothiazine (ML171) 2-Acetylphenothiazine (ML171, 2-APT) is a potent and selective inhibitor of NADPH-oxidase with IC50s of 0.25 μM, 5 μM, 3μM, 5 μM and 5.5 μM for NOX1, NOX2, NOX3, NOX4 and xanthine oxidase, respectively.
Front Plant Sci, 2024, 15:1418049
PLoS One, 2023, 18(5):e0285206
Cancers (Basel), 2022, 14(11)2643
S9617 G6PDi-1 G6PDi-1 is an effective inhibitor of glucose-6-phosphate dehydrogenase (G6PD). G6PDi-1 depletes NADPH and decreases inflammatory cytokine production.
EMBO J, 2023, e110620.
S0777 Isuzinaxib (APX-115 free base) Isuzinaxib (APX-115 free base, Ewha-18278 free base) is a potent, orally active inhibitor of pan NADPH oxidase (pan-Nox) with Ki of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 free base (Ewha-18278 free base) significantly suppresses the expression of inflammatory molecules including MCP-1/CCL2, IL-6, and TNFα in the diabetic kidney.
S2425 Apocynin Apocynin is a selective NADPH-oxidase inhibitor with IC50 of 10 μM.
Antioxidants (Basel), 2023, 12(1)145
Antioxidants (Basel), 2023, 12(1)145
J Am Heart Assoc, 2023, 12(15):e029415
S2348 Rotenone Rotenone is a botanical insecticide that is an inhibitor of mitochondrial electron transport. Rotenone inhibits NADH/DB oxidoreductase and NADH oxidase with IC50 of 28.8 nM and 5.1 nM, respectively. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.Rotenone can be used to induce animal models of Parkinson's Disease.
Cell Rep Med, 2024, 5(5):101519
Redox Biol, 2024, 70:103039
Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6):167249
S7171 Setanaxib (GKT137831) Setanaxib (GKT137831, GKT831) is a potent, dual NADPH oxidase NOX1/NOX4 inhibitor with Ki of 110 nM and 140 nM, respectively. Treatment with GKT137831 suppresses reactive oxygen species (ROS) production. GKT137831 partly inhibits ferroptosis.
Immunity, 2024, 57(1):52-67.e10
Nat Commun, 2024, 15(1):8663
MedComm (2020), 2024, 5(8):e668
S8639 DPI (Diphenyleneiodonium chloride) DPI (Diphenyleneiodonium chloride) is an inhibitor of NADPH oxidase and also a potent, irreversible, and time-, temperature-dependent iNOS/eNOS inhibitor. Diphenyleneiodonium chloride (DPI) also functions as a TRPA1 activator and selectively inhibits intracellular reactive oxygen species (ROS).
Cell Death Discov, 2024, 10(1):122
PLoS Pathog, 2024, 20(9):e1012553
Int Immunopharmacol, 2024, 143(Pt 2):113504
S6656 VAS2870 VAS2870 is a pan-NADPH oxidase (NOX) inhibitor.
Front Oncol, 2024, 14:1438306
J Nanobiotechnology, 2023, 21(1):117
Biomaterials, 2021, 271:120720
S8974 GSK2795039 GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.
Open Med (Wars), 2024, 19(1):20240898
Int J Mol Sci, 2023, 24(18)14369
Int J Mol Sci, 2023, 10.3390/ijms241814369
S0178 GLX351322 GLX351322 is a NADPH oxidase 4 (NOX4) inhibitor. GLX351322 inhibits hydrogen peroxide production from tetracycline inducible NOX4-overexpressing cells with IC50 of 5 μM.
Cell Commun Signal, 2024, 22(1):393
Cell Commun Signal, 2024, 22(1):393.
Biomed Pharmacother, 2023, 165:115052
S5304 2-Acetylphenothiazine (ML171) 2-Acetylphenothiazine (ML171, 2-APT) is a potent and selective inhibitor of NADPH-oxidase with IC50s of 0.25 μM, 5 μM, 3μM, 5 μM and 5.5 μM for NOX1, NOX2, NOX3, NOX4 and xanthine oxidase, respectively.
Front Plant Sci, 2024, 15:1418049
PLoS One, 2023, 18(5):e0285206
Cancers (Basel), 2022, 14(11)2643
S9617 G6PDi-1 G6PDi-1 is an effective inhibitor of glucose-6-phosphate dehydrogenase (G6PD). G6PDi-1 depletes NADPH and decreases inflammatory cytokine production.
EMBO J, 2023, e110620.
S0777 Isuzinaxib (APX-115 free base) Isuzinaxib (APX-115 free base, Ewha-18278 free base) is a potent, orally active inhibitor of pan NADPH oxidase (pan-Nox) with Ki of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 free base (Ewha-18278 free base) significantly suppresses the expression of inflammatory molecules including MCP-1/CCL2, IL-6, and TNFα in the diabetic kidney.
S2425 Apocynin Apocynin is a selective NADPH-oxidase inhibitor with IC50 of 10 μM.
Antioxidants (Basel), 2023, 12(1)145
Antioxidants (Basel), 2023, 12(1)145
J Am Heart Assoc, 2023, 12(15):e029415
S2348 Rotenone Rotenone is a botanical insecticide that is an inhibitor of mitochondrial electron transport. Rotenone inhibits NADH/DB oxidoreductase and NADH oxidase with IC50 of 28.8 nM and 5.1 nM, respectively. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.Rotenone can be used to induce animal models of Parkinson's Disease.
Cell Rep Med, 2024, 5(5):101519
Redox Biol, 2024, 70:103039
Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6):167249

Choose Selective NADPH-oxidase Inhibitors

Tags: NADPH-oxidase inhibitor|NADPH-oxidase agonist|NADPH-oxidase activator|NADPH-oxidase inducer|NADPH-oxidase antagonist|NADPH-oxidase signaling pathway|NADPH-oxidase assay kit